Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial

BACKGROUND. We previously demonstrated the noninferiority of switching to efavirenz (EFV) versus remaining on ritonavir-boosted lopinavir (LPV/r) for virologic control in children infected with human immunodeficiency virus (HIV) and exposed to nevirapine (NVP) for prevention of mother-to-child trans...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Murnane, Pamela M., Strehlau, Renate, Shiau, Stephanie, Patel, Faeezah, Mbete, Ndileke, Hunt, Gillian, Abrams, Elaine J., Coovadia, Ashraf, Kuhn, Louise
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Major Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849095/
https://ncbi.nlm.nih.gov/pubmed/28419200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix335
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky